CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 72 filers reported holding CYTOSORBENTS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $661,000 | -69.7% | 131,472 | -60.2% | 0.00% | -50.0% |
| Q2 2019 | $2,182,000 | -13.4% | 330,086 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $2,520,000 | -7.4% | 332,870 | -1.1% | 0.00% | -33.3% |
| Q4 2018 | $2,720,000 | -39.8% | 336,632 | -3.9% | 0.00% | -25.0% |
| Q3 2018 | $4,517,000 | +53.8% | 350,178 | +35.9% | 0.00% | +33.3% |
| Q2 2018 | $2,937,000 | – | 257,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |